nodes	percent_of_prediction	percent_of_DWPC	metapath
Naratriptan—migraine—Prednisone—ankylosing spondylitis	0.845	1	CpDpCtD
Naratriptan—HTR1B—dura mater—ankylosing spondylitis	0.0288	0.5	CbGeAlD
Naratriptan—HTR1D—dura mater—ankylosing spondylitis	0.0279	0.484	CbGeAlD
Naratriptan—MAOA—tendon—ankylosing spondylitis	0.000923	0.016	CbGeAlD
Naratriptan—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.000195	0.002	CcSEcCtD
Naratriptan—Bradycardia—Prednisone—ankylosing spondylitis	0.000194	0.00199	CcSEcCtD
Naratriptan—Alopecia—Dexamethasone—ankylosing spondylitis	0.000194	0.00199	CcSEcCtD
Naratriptan—Alopecia—Betamethasone—ankylosing spondylitis	0.000194	0.00199	CcSEcCtD
Naratriptan—Discomfort—Prednisolone—ankylosing spondylitis	0.000192	0.00197	CcSEcCtD
Naratriptan—Haemoglobin—Prednisone—ankylosing spondylitis	0.000192	0.00197	CcSEcCtD
Naratriptan—Abdominal discomfort—Methotrexate—ankylosing spondylitis	0.000191	0.00196	CcSEcCtD
Naratriptan—Haemorrhage—Prednisone—ankylosing spondylitis	0.000191	0.00196	CcSEcCtD
Naratriptan—Erythema—Betamethasone—ankylosing spondylitis	0.000191	0.00196	CcSEcCtD
Naratriptan—Erythema—Dexamethasone—ankylosing spondylitis	0.000191	0.00196	CcSEcCtD
Naratriptan—Hallucination—Prednisone—ankylosing spondylitis	0.00019	0.00195	CcSEcCtD
Naratriptan—Malaise—Triamcinolone—ankylosing spondylitis	0.00019	0.00194	CcSEcCtD
Naratriptan—Malaise—Methylprednisolone—ankylosing spondylitis	0.000189	0.00194	CcSEcCtD
Naratriptan—Vertigo—Triamcinolone—ankylosing spondylitis	0.000189	0.00194	CcSEcCtD
Naratriptan—Syncope—Triamcinolone—ankylosing spondylitis	0.000188	0.00193	CcSEcCtD
Naratriptan—Vertigo—Methylprednisolone—ankylosing spondylitis	0.000188	0.00193	CcSEcCtD
Naratriptan—Syncope—Methylprednisolone—ankylosing spondylitis	0.000188	0.00193	CcSEcCtD
Naratriptan—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.000187	0.00191	CcSEcCtD
Naratriptan—Oedema—Prednisolone—ankylosing spondylitis	0.000187	0.00191	CcSEcCtD
Naratriptan—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.000185	0.0019	CcSEcCtD
Naratriptan—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.000184	0.00189	CcSEcCtD
Naratriptan—Shock—Prednisolone—ankylosing spondylitis	0.000184	0.00188	CcSEcCtD
Naratriptan—Cough—Triamcinolone—ankylosing spondylitis	0.000183	0.00188	CcSEcCtD
Naratriptan—Convulsion—Triamcinolone—ankylosing spondylitis	0.000182	0.00187	CcSEcCtD
Naratriptan—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	0.000182	0.00187	CcSEcCtD
Naratriptan—Convulsion—Methylprednisolone—ankylosing spondylitis	0.000182	0.00186	CcSEcCtD
Naratriptan—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00018	0.00185	CcSEcCtD
Naratriptan—Myalgia—Triamcinolone—ankylosing spondylitis	0.000179	0.00184	CcSEcCtD
Naratriptan—Pneumonia—Methotrexate—ankylosing spondylitis	0.000179	0.00183	CcSEcCtD
Naratriptan—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000179	0.00183	CcSEcCtD
Naratriptan—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000179	0.00183	CcSEcCtD
Naratriptan—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000178	0.00183	CcSEcCtD
Naratriptan—Drowsiness—Methotrexate—ankylosing spondylitis	0.000178	0.00182	CcSEcCtD
Naratriptan—Depression—Methotrexate—ankylosing spondylitis	0.000177	0.00182	CcSEcCtD
Naratriptan—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000177	0.00182	CcSEcCtD
Naratriptan—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000177	0.00182	CcSEcCtD
Naratriptan—Discomfort—Triamcinolone—ankylosing spondylitis	0.000177	0.00181	CcSEcCtD
Naratriptan—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000176	0.00181	CcSEcCtD
Naratriptan—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000175	0.0018	CcSEcCtD
Naratriptan—Angiopathy—Prednisone—ankylosing spondylitis	0.000173	0.00178	CcSEcCtD
Naratriptan—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000173	0.00177	CcSEcCtD
Naratriptan—Immune system disorder—Prednisone—ankylosing spondylitis	0.000172	0.00177	CcSEcCtD
Naratriptan—Malaise—Dexamethasone—ankylosing spondylitis	0.000172	0.00176	CcSEcCtD
Naratriptan—Malaise—Betamethasone—ankylosing spondylitis	0.000172	0.00176	CcSEcCtD
Naratriptan—Oedema—Triamcinolone—ankylosing spondylitis	0.000172	0.00176	CcSEcCtD
Naratriptan—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000172	0.00176	CcSEcCtD
Naratriptan—Vertigo—Betamethasone—ankylosing spondylitis	0.000171	0.00176	CcSEcCtD
Naratriptan—Vertigo—Dexamethasone—ankylosing spondylitis	0.000171	0.00176	CcSEcCtD
Naratriptan—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000171	0.00176	CcSEcCtD
Naratriptan—Syncope—Dexamethasone—ankylosing spondylitis	0.000171	0.00175	CcSEcCtD
Naratriptan—Syncope—Betamethasone—ankylosing spondylitis	0.000171	0.00175	CcSEcCtD
Naratriptan—Arrhythmia—Prednisone—ankylosing spondylitis	0.00017	0.00175	CcSEcCtD
Naratriptan—Infection—Triamcinolone—ankylosing spondylitis	0.00017	0.00175	CcSEcCtD
Naratriptan—Sweating—Methotrexate—ankylosing spondylitis	0.00017	0.00175	CcSEcCtD
Naratriptan—Infection—Methylprednisolone—ankylosing spondylitis	0.00017	0.00174	CcSEcCtD
Naratriptan—Shock—Triamcinolone—ankylosing spondylitis	0.000169	0.00173	CcSEcCtD
Naratriptan—Alopecia—Prednisone—ankylosing spondylitis	0.000169	0.00173	CcSEcCtD
Naratriptan—Shock—Methylprednisolone—ankylosing spondylitis	0.000168	0.00173	CcSEcCtD
Naratriptan—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000168	0.00172	CcSEcCtD
Naratriptan—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000168	0.00172	CcSEcCtD
Naratriptan—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000168	0.00172	CcSEcCtD
Naratriptan—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000167	0.00172	CcSEcCtD
Naratriptan—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000166	0.00171	CcSEcCtD
Naratriptan—Erythema—Prednisone—ankylosing spondylitis	0.000166	0.0017	CcSEcCtD
Naratriptan—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000166	0.0017	CcSEcCtD
Naratriptan—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000165	0.0017	CcSEcCtD
Naratriptan—Convulsion—Dexamethasone—ankylosing spondylitis	0.000165	0.0017	CcSEcCtD
Naratriptan—Convulsion—Betamethasone—ankylosing spondylitis	0.000165	0.0017	CcSEcCtD
Naratriptan—Myalgia—Betamethasone—ankylosing spondylitis	0.000162	0.00167	CcSEcCtD
Naratriptan—Myalgia—Dexamethasone—ankylosing spondylitis	0.000162	0.00167	CcSEcCtD
Naratriptan—Anxiety—Betamethasone—ankylosing spondylitis	0.000162	0.00166	CcSEcCtD
Naratriptan—Anxiety—Dexamethasone—ankylosing spondylitis	0.000162	0.00166	CcSEcCtD
Naratriptan—Discomfort—Dexamethasone—ankylosing spondylitis	0.00016	0.00165	CcSEcCtD
Naratriptan—Discomfort—Betamethasone—ankylosing spondylitis	0.00016	0.00165	CcSEcCtD
Naratriptan—Haemoglobin—Methotrexate—ankylosing spondylitis	0.00016	0.00164	CcSEcCtD
Naratriptan—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00016	0.00164	CcSEcCtD
Naratriptan—Pain—Prednisolone—ankylosing spondylitis	0.00016	0.00164	CcSEcCtD
Naratriptan—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000159	0.00164	CcSEcCtD
Naratriptan—Vision blurred—Prednisone—ankylosing spondylitis	0.000157	0.00161	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000156	0.0016	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000156	0.0016	CcSEcCtD
Naratriptan—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000156	0.0016	CcSEcCtD
Naratriptan—Oedema—Betamethasone—ankylosing spondylitis	0.000156	0.0016	CcSEcCtD
Naratriptan—Oedema—Dexamethasone—ankylosing spondylitis	0.000156	0.0016	CcSEcCtD
Naratriptan—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000156	0.0016	CcSEcCtD
Naratriptan—Infection—Dexamethasone—ankylosing spondylitis	0.000155	0.00159	CcSEcCtD
Naratriptan—Infection—Betamethasone—ankylosing spondylitis	0.000155	0.00159	CcSEcCtD
Naratriptan—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000154	0.00158	CcSEcCtD
Naratriptan—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000154	0.00158	CcSEcCtD
Naratriptan—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000154	0.00158	CcSEcCtD
Naratriptan—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000154	0.00158	CcSEcCtD
Naratriptan—Anaemia—Prednisone—ankylosing spondylitis	0.000153	0.00157	CcSEcCtD
Naratriptan—Shock—Betamethasone—ankylosing spondylitis	0.000153	0.00157	CcSEcCtD
Naratriptan—Shock—Dexamethasone—ankylosing spondylitis	0.000153	0.00157	CcSEcCtD
Naratriptan—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000153	0.00157	CcSEcCtD
Naratriptan—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000153	0.00157	CcSEcCtD
Naratriptan—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000153	0.00157	CcSEcCtD
Naratriptan—Agitation—Prednisone—ankylosing spondylitis	0.000153	0.00157	CcSEcCtD
Naratriptan—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000152	0.00156	CcSEcCtD
Naratriptan—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000152	0.00156	CcSEcCtD
Naratriptan—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00015	0.00154	CcSEcCtD
Naratriptan—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00015	0.00154	CcSEcCtD
Naratriptan—Malaise—Prednisone—ankylosing spondylitis	0.00015	0.00154	CcSEcCtD
Naratriptan—Vertigo—Prednisone—ankylosing spondylitis	0.000149	0.00153	CcSEcCtD
Naratriptan—Syncope—Prednisone—ankylosing spondylitis	0.000149	0.00153	CcSEcCtD
Naratriptan—Tinnitus—Methotrexate—ankylosing spondylitis	0.000149	0.00153	CcSEcCtD
Naratriptan—Urticaria—Prednisolone—ankylosing spondylitis	0.000148	0.00152	CcSEcCtD
Naratriptan—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000148	0.00152	CcSEcCtD
Naratriptan—Fatigue—Triamcinolone—ankylosing spondylitis	0.000148	0.00152	CcSEcCtD
Naratriptan—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000148	0.00151	CcSEcCtD
Naratriptan—Pain—Triamcinolone—ankylosing spondylitis	0.000147	0.0015	CcSEcCtD
Naratriptan—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000146	0.0015	CcSEcCtD
Naratriptan—Hypotension—Dexamethasone—ankylosing spondylitis	0.000145	0.00149	CcSEcCtD
Naratriptan—Hypotension—Betamethasone—ankylosing spondylitis	0.000145	0.00149	CcSEcCtD
Naratriptan—Angiopathy—Methotrexate—ankylosing spondylitis	0.000145	0.00148	CcSEcCtD
Naratriptan—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000144	0.00148	CcSEcCtD
Naratriptan—Convulsion—Prednisone—ankylosing spondylitis	0.000144	0.00148	CcSEcCtD
Naratriptan—Chills—Methotrexate—ankylosing spondylitis	0.000143	0.00147	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000142	0.00145	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000142	0.00145	CcSEcCtD
Naratriptan—Arthralgia—Prednisone—ankylosing spondylitis	0.000141	0.00145	CcSEcCtD
Naratriptan—Myalgia—Prednisone—ankylosing spondylitis	0.000141	0.00145	CcSEcCtD
Naratriptan—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000141	0.00145	CcSEcCtD
Naratriptan—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000141	0.00145	CcSEcCtD
Naratriptan—Anxiety—Prednisone—ankylosing spondylitis	0.000141	0.00145	CcSEcCtD
Naratriptan—Alopecia—Methotrexate—ankylosing spondylitis	0.000141	0.00145	CcSEcCtD
Naratriptan—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00014	0.00143	CcSEcCtD
Naratriptan—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00014	0.00143	CcSEcCtD
Naratriptan—Discomfort—Prednisone—ankylosing spondylitis	0.00014	0.00143	CcSEcCtD
Naratriptan—Erythema—Methotrexate—ankylosing spondylitis	0.000139	0.00142	CcSEcCtD
Naratriptan—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000137	0.00141	CcSEcCtD
Naratriptan—Urticaria—Triamcinolone—ankylosing spondylitis	0.000136	0.0014	CcSEcCtD
Naratriptan—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000136	0.00139	CcSEcCtD
Naratriptan—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000136	0.00139	CcSEcCtD
Naratriptan—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000136	0.00139	CcSEcCtD
Naratriptan—Oedema—Prednisone—ankylosing spondylitis	0.000136	0.00139	CcSEcCtD
Naratriptan—Infection—Prednisone—ankylosing spondylitis	0.000135	0.00138	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000134	0.00138	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000134	0.00138	CcSEcCtD
Naratriptan—Fatigue—Dexamethasone—ankylosing spondylitis	0.000134	0.00138	CcSEcCtD
Naratriptan—Fatigue—Betamethasone—ankylosing spondylitis	0.000134	0.00138	CcSEcCtD
Naratriptan—Shock—Prednisone—ankylosing spondylitis	0.000133	0.00137	CcSEcCtD
Naratriptan—Pain—Dexamethasone—ankylosing spondylitis	0.000133	0.00137	CcSEcCtD
Naratriptan—Pain—Betamethasone—ankylosing spondylitis	0.000133	0.00137	CcSEcCtD
Naratriptan—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000133	0.00136	CcSEcCtD
Naratriptan—Skin disorder—Prednisone—ankylosing spondylitis	0.000132	0.00135	CcSEcCtD
Naratriptan—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000131	0.00134	CcSEcCtD
Naratriptan—Vision blurred—Methotrexate—ankylosing spondylitis	0.000131	0.00134	CcSEcCtD
Naratriptan—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000129	0.00132	CcSEcCtD
Naratriptan—Anaemia—Methotrexate—ankylosing spondylitis	0.000128	0.00132	CcSEcCtD
Naratriptan—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000128	0.00132	CcSEcCtD
Naratriptan—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000128	0.00132	CcSEcCtD
Naratriptan—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000126	0.0013	CcSEcCtD
Naratriptan—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000126	0.00129	CcSEcCtD
Naratriptan—Malaise—Methotrexate—ankylosing spondylitis	0.000125	0.00128	CcSEcCtD
Naratriptan—Vertigo—Methotrexate—ankylosing spondylitis	0.000125	0.00128	CcSEcCtD
Naratriptan—Urticaria—Dexamethasone—ankylosing spondylitis	0.000124	0.00127	CcSEcCtD
Naratriptan—Urticaria—Betamethasone—ankylosing spondylitis	0.000124	0.00127	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000123	0.00127	CcSEcCtD
Naratriptan—Dizziness—Prednisolone—ankylosing spondylitis	0.000123	0.00127	CcSEcCtD
Naratriptan—Asthenia—Triamcinolone—ankylosing spondylitis	0.000123	0.00126	CcSEcCtD
Naratriptan—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000123	0.00126	CcSEcCtD
Naratriptan—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000123	0.00126	CcSEcCtD
Naratriptan—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000123	0.00126	CcSEcCtD
Naratriptan—Paraesthesia—Prednisone—ankylosing spondylitis	0.000122	0.00125	CcSEcCtD
Naratriptan—Pruritus—Triamcinolone—ankylosing spondylitis	0.000121	0.00125	CcSEcCtD
Naratriptan—Cough—Methotrexate—ankylosing spondylitis	0.000121	0.00124	CcSEcCtD
Naratriptan—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000121	0.00124	CcSEcCtD
Naratriptan—Convulsion—Methotrexate—ankylosing spondylitis	0.00012	0.00123	CcSEcCtD
Naratriptan—Myalgia—Methotrexate—ankylosing spondylitis	0.000118	0.00121	CcSEcCtD
Naratriptan—Arthralgia—Methotrexate—ankylosing spondylitis	0.000118	0.00121	CcSEcCtD
Naratriptan—Rash—Prednisolone—ankylosing spondylitis	0.000118	0.00121	CcSEcCtD
Naratriptan—Dermatitis—Prednisolone—ankylosing spondylitis	0.000117	0.00121	CcSEcCtD
Naratriptan—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000117	0.0012	CcSEcCtD
Naratriptan—Fatigue—Prednisone—ankylosing spondylitis	0.000117	0.0012	CcSEcCtD
Naratriptan—Headache—Prednisolone—ankylosing spondylitis	0.000117	0.0012	CcSEcCtD
Naratriptan—Discomfort—Methotrexate—ankylosing spondylitis	0.000117	0.0012	CcSEcCtD
Naratriptan—Constipation—Prednisone—ankylosing spondylitis	0.000116	0.00119	CcSEcCtD
Naratriptan—Confusional state—Methotrexate—ankylosing spondylitis	0.000114	0.00117	CcSEcCtD
Naratriptan—Dizziness—Triamcinolone—ankylosing spondylitis	0.000113	0.00116	CcSEcCtD
Naratriptan—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000113	0.00116	CcSEcCtD
Naratriptan—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000113	0.00116	CcSEcCtD
Naratriptan—Infection—Methotrexate—ankylosing spondylitis	0.000113	0.00115	CcSEcCtD
Naratriptan—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000112	0.00115	CcSEcCtD
Naratriptan—Asthenia—Dexamethasone—ankylosing spondylitis	0.000112	0.00115	CcSEcCtD
Naratriptan—Asthenia—Betamethasone—ankylosing spondylitis	0.000112	0.00115	CcSEcCtD
Naratriptan—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000111	0.00114	CcSEcCtD
Naratriptan—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000111	0.00114	CcSEcCtD
Naratriptan—Nausea—Prednisolone—ankylosing spondylitis	0.000111	0.00114	CcSEcCtD
Naratriptan—Pruritus—Dexamethasone—ankylosing spondylitis	0.00011	0.00113	CcSEcCtD
Naratriptan—Pruritus—Betamethasone—ankylosing spondylitis	0.00011	0.00113	CcSEcCtD
Naratriptan—Skin disorder—Methotrexate—ankylosing spondylitis	0.00011	0.00113	CcSEcCtD
Naratriptan—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00011	0.00112	CcSEcCtD
Naratriptan—Vomiting—Triamcinolone—ankylosing spondylitis	0.000109	0.00112	CcSEcCtD
Naratriptan—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000109	0.00112	CcSEcCtD
Naratriptan—Rash—Triamcinolone—ankylosing spondylitis	0.000108	0.00111	CcSEcCtD
Naratriptan—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000108	0.00111	CcSEcCtD
Naratriptan—Rash—Methylprednisolone—ankylosing spondylitis	0.000108	0.00111	CcSEcCtD
Naratriptan—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000108	0.00111	CcSEcCtD
Naratriptan—Urticaria—Prednisone—ankylosing spondylitis	0.000108	0.0011	CcSEcCtD
Naratriptan—Headache—Triamcinolone—ankylosing spondylitis	0.000107	0.0011	CcSEcCtD
Naratriptan—Headache—Methylprednisolone—ankylosing spondylitis	0.000107	0.0011	CcSEcCtD
Naratriptan—Body temperature increased—Prednisone—ankylosing spondylitis	0.000107	0.0011	CcSEcCtD
Naratriptan—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000106	0.00109	CcSEcCtD
Naratriptan—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000106	0.00109	CcSEcCtD
Naratriptan—Hypotension—Methotrexate—ankylosing spondylitis	0.000106	0.00109	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000103	0.00106	CcSEcCtD
Naratriptan—Dizziness—Dexamethasone—ankylosing spondylitis	0.000103	0.00106	CcSEcCtD
Naratriptan—Dizziness—Betamethasone—ankylosing spondylitis	0.000103	0.00106	CcSEcCtD
Naratriptan—Nausea—Triamcinolone—ankylosing spondylitis	0.000102	0.00105	CcSEcCtD
Naratriptan—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000102	0.00104	CcSEcCtD
Naratriptan—Nausea—Methylprednisolone—ankylosing spondylitis	0.000102	0.00104	CcSEcCtD
Naratriptan—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000101	0.00104	CcSEcCtD
Naratriptan—Somnolence—Methotrexate—ankylosing spondylitis	0.000101	0.00103	CcSEcCtD
Naratriptan—Hypersensitivity—Prednisone—ankylosing spondylitis	9.99e-05	0.00102	CcSEcCtD
Naratriptan—Vomiting—Dexamethasone—ankylosing spondylitis	9.9e-05	0.00102	CcSEcCtD
Naratriptan—Vomiting—Betamethasone—ankylosing spondylitis	9.9e-05	0.00102	CcSEcCtD
Naratriptan—Rash—Dexamethasone—ankylosing spondylitis	9.81e-05	0.00101	CcSEcCtD
Naratriptan—Rash—Betamethasone—ankylosing spondylitis	9.81e-05	0.00101	CcSEcCtD
Naratriptan—Dermatitis—Betamethasone—ankylosing spondylitis	9.8e-05	0.00101	CcSEcCtD
Naratriptan—Dermatitis—Dexamethasone—ankylosing spondylitis	9.8e-05	0.00101	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	9.78e-05	0.001	CcSEcCtD
Naratriptan—Fatigue—Methotrexate—ankylosing spondylitis	9.77e-05	0.001	CcSEcCtD
Naratriptan—Headache—Dexamethasone—ankylosing spondylitis	9.75e-05	0.001	CcSEcCtD
Naratriptan—Headache—Betamethasone—ankylosing spondylitis	9.75e-05	0.001	CcSEcCtD
Naratriptan—Asthenia—Prednisone—ankylosing spondylitis	9.72e-05	0.000998	CcSEcCtD
Naratriptan—Pain—Methotrexate—ankylosing spondylitis	9.69e-05	0.000994	CcSEcCtD
Naratriptan—Pruritus—Prednisone—ankylosing spondylitis	9.59e-05	0.000984	CcSEcCtD
Naratriptan—Feeling abnormal—Methotrexate—ankylosing spondylitis	9.33e-05	0.000958	CcSEcCtD
Naratriptan—Diarrhoea—Prednisone—ankylosing spondylitis	9.27e-05	0.000951	CcSEcCtD
Naratriptan—Nausea—Betamethasone—ankylosing spondylitis	9.24e-05	0.000948	CcSEcCtD
Naratriptan—Nausea—Dexamethasone—ankylosing spondylitis	9.24e-05	0.000948	CcSEcCtD
Naratriptan—Urticaria—Methotrexate—ankylosing spondylitis	9e-05	0.000923	CcSEcCtD
Naratriptan—Dizziness—Prednisone—ankylosing spondylitis	8.96e-05	0.00092	CcSEcCtD
Naratriptan—Body temperature increased—Methotrexate—ankylosing spondylitis	8.95e-05	0.000919	CcSEcCtD
Naratriptan—Vomiting—Prednisone—ankylosing spondylitis	8.62e-05	0.000884	CcSEcCtD
Naratriptan—Rash—Prednisone—ankylosing spondylitis	8.55e-05	0.000877	CcSEcCtD
Naratriptan—Dermatitis—Prednisone—ankylosing spondylitis	8.54e-05	0.000876	CcSEcCtD
Naratriptan—Headache—Prednisone—ankylosing spondylitis	8.49e-05	0.000871	CcSEcCtD
Naratriptan—Hypersensitivity—Methotrexate—ankylosing spondylitis	8.35e-05	0.000856	CcSEcCtD
Naratriptan—Asthenia—Methotrexate—ankylosing spondylitis	8.13e-05	0.000834	CcSEcCtD
Naratriptan—Nausea—Prednisone—ankylosing spondylitis	8.05e-05	0.000826	CcSEcCtD
Naratriptan—Pruritus—Methotrexate—ankylosing spondylitis	8.01e-05	0.000822	CcSEcCtD
Naratriptan—Diarrhoea—Methotrexate—ankylosing spondylitis	7.75e-05	0.000795	CcSEcCtD
Naratriptan—Dizziness—Methotrexate—ankylosing spondylitis	7.49e-05	0.000768	CcSEcCtD
Naratriptan—Vomiting—Methotrexate—ankylosing spondylitis	7.2e-05	0.000739	CcSEcCtD
Naratriptan—Rash—Methotrexate—ankylosing spondylitis	7.14e-05	0.000733	CcSEcCtD
Naratriptan—Dermatitis—Methotrexate—ankylosing spondylitis	7.14e-05	0.000732	CcSEcCtD
Naratriptan—Headache—Methotrexate—ankylosing spondylitis	7.1e-05	0.000728	CcSEcCtD
Naratriptan—Nausea—Methotrexate—ankylosing spondylitis	6.73e-05	0.00069	CcSEcCtD
